TipRanks
AstraZeneca Pharma India Limited (IN:ASTRAZEN)
:ASTRAZEN
India Market
ASTRAZEN
AstraZeneca Pharma India Limited
RESEARCH TOOLSreports
Want to see IN:ASTRAZEN full AI Analyst Report?

AstraZeneca Pharma India Limited (ASTRAZEN) Income Statement

40 Followers

AstraZeneca Pharma India Limited Income Statement

Last quarter (Q1 2027), AstraZeneca Pharma India Limited's total revenue was ₹6.83B, an increase of 29.73% from the same quarter last year. In Q1, AstraZeneca Pharma India Limited's net income was ₹379.30M. See AstraZeneca Pharma India Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
₹ 22.76B₹ 17.13B₹ 12.96B₹ 10.03B₹ 8.06B
Gross Profit
₹ 6.02B₹ 7.13B₹ 6.22B₹ 5.78B₹ 4.48B
Operating Expenses
₹ 3.69B₹ 4.98B₹ 4.51B₹ 4.29B₹ 3.78B
Depreciation and Amortization
₹ 285.80M₹ 399.90M₹ 149.40M₹ 162.60M₹ 169.50M
EBITDA
₹ 2.85B₹ 1.98B₹ 2.36B₹ 1.51B₹ 1.01B
Operating Income
₹ 2.33B₹ 2.15B₹ 1.71B₹ 1.49B₹ 696.50M
Other Income/Expenses
₹ 187.50M₹ -584.50M₹ 481.10M₹ -147.90M₹ 133.90M
Pretax Income
₹ 2.52B₹ 1.56B₹ 2.20B₹ 1.34B₹ 830.40M
Net Income
₹ 1.88B₹ 1.16B₹ 1.62B₹ 992.90M₹ 616.00M
Per Share Metrics
Basic EPS
₹ 75.01₹ 46.30₹ 64.60₹ 39.72₹ 24.64
Diluted EPS
₹ 75.01₹ 46.30₹ 64.60₹ 39.72₹ 24.64
Weighted Average Shares Outstanding
 25.00M 25.00M 25.00M 25.00M 25.00M
Weighted Average Shares Outstanding (Diluted)
 25.00M 25.00M 25.00M 25.00M 25.00M
Currency in INR

AstraZeneca Pharma India Limited Earnings and Revenue History